RxDoctor Payments Data

Rhonda Manessier, PA

Physician Assistant · Garland, TXNPI 1083644272

Payments from drug & device makers

$2,120in general payments, 2019–2025

Across 120 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$322
  • Dexcom, Inc.$263
  • Lilly USA, LLC$159
  • AstraZeneca$136
  • Astellas Pharma US Inc$124
  • Novo Nordisk$116
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,120100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,120 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$66,035
Medicare patients
293
Services billed
1,618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$46,196
JardianceEmpagliflozin19$30,803
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,363
Rosuvastatin Calcium46$2,719
Gabapentin73$1,550
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$1,230
SynthroidLevothyroxine Sodium21$1,211
Losartan Potassium41$1,066
Atorvastatin Calcium150$947
Albuterol Sulfate HfaAlbuterol Sulfate31$909
ValacyclovirValacyclovir Hcl16$786
Levothyroxine Sodium102$749
Montelukast Sodium71$739
Ondansetron OdtOndansetron22$661
Cefdinir35$600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$116$46,19634 claims
Boehringer IngelheimJardiance$82$30,80319 claims
GSKAnoro Ellipta$86$4,36311 claims
AbbVieSynthroid$104$1,21121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Garland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →